Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (1y) (2013 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 15.11% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | -5.04% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 390.91% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 74.08% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 265.56% |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -14.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.08% |
| Mar 31, 2026 | 15.06% |
| Dec 31, 2025 | 762.14% |
| Sep 30, 2025 | 280.32% |
| Jun 30, 2025 | 7.72% |
| Mar 31, 2025 | 148.42% |
| Dec 31, 2024 | 150.00% |
| Sep 30, 2024 | 187.02% |
| Jun 30, 2024 | 34.58% |
| Mar 31, 2024 | -16.30% |
| Dec 31, 2023 | -82.33% |
| Sep 30, 2023 | -307.86% |
| Jun 30, 2023 | 28.70% |
| Mar 31, 2023 | -43.23% |
| Dec 31, 2022 | -58.72% |
| Sep 30, 2022 | -40.99% |
| Jun 30, 2022 | -55.26% |
| Mar 31, 2022 | 45.46% |
| Dec 31, 2021 | 36.43% |
| Sep 30, 2021 | -46.89% |